These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 13408766)

  • 1. [Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
    BERNARD J; MATHE G; WEIL M
    Rev Fr Etud Clin Biol; 1956 Dec; 1(10):1121-32. PubMed ID: 13408766
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
    BERNARD J; MATHE G; WEIL M
    Sang; 1957; 28(1):80-2. PubMed ID: 13432604
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
    KIELER J
    Acta radiol; 1951 Dec; 36(6):461-8. PubMed ID: 14902587
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
    KLIMA R; HORNISCHER R
    Wien Med Wochenschr; 1953 Jan; 103(1):11-4. PubMed ID: 13049846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
    ZULIK R
    Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of the resistant stages of Hodgkin's disease and lymphoblastic diseases.
    HOCHMAN A; ICKOWICZ M
    Br J Radiol; 1954 Aug; 27(320):467-9. PubMed ID: 13182191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination of microdosage of chloralkylamines with roentgen irradiation in the treatment of hemoblastoses and hemoblastomas].
    VESIN S
    Cas Lek Cesk; 1952 Nov; 91(45-46):1384-7. PubMed ID: 14390440
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimentation with actinomycin].
    HUGUENIN R; TRUHAUT R; BOURDIN JS
    Presse Med (1893); 1954 May; 62(35):740. PubMed ID: 13177453
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma].
    NARDI FL
    Accad Medica; 1952 Apr; 67(4):169-77. PubMed ID: 12984986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hemoblastosis with triethylene melamine].
    LINKE A; LASCH HG
    Dtsch Med Wochenschr; 1953 Jun; 78(25):911-6. PubMed ID: 13068032
    [No Abstract]   [Full Text] [Related]  

  • 11. Triethylene melamine (TEM) in the treatment of malignant lymphoid disease.
    HAMBLY CK; ROBERTSON TI
    Med J Aust; 1955 Jun; 42(1 25):900-11. PubMed ID: 13243982
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic use of embichin].
    SOROKIN NM
    Klin Med (Mosk); 1954 Jun; 32(6):75-7. PubMed ID: 13192973
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trials with triethylene melamine].
    FERRARI M; KASDORF H
    Arch Urug Med Cir Espec; 1953; 42(3-4):134-44. PubMed ID: 14350952
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of Hodgkin's disease and the lymphosarcomas.
    MEYER OO
    J Am Med Assoc; 1954 Jan; 154(2):114-20. PubMed ID: 13108678
    [No Abstract]   [Full Text] [Related]  

  • 15. [When to terminate the treatment of children with Hodgkin's disease, lymphoblastic leukemia and non-Hodgkin's lymphoma. Analysis of 80 cases].
    Armata J
    Pediatr Pol; 1979 Aug; 54(8):877-85. PubMed ID: 291888
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of malignant lymphomas and lymphadenoses with leukeran.
    LIBANSKY J; CHUDOMEL V; BRABEC V; SOCHMAN J
    Neoplasma; 1959; 6():415-24. PubMed ID: 14416684
    [No Abstract]   [Full Text] [Related]  

  • 17. [Value and action of cytostatics in malignant lymphatic system diseases].
    FLEISCHHACKER H; STACHER A
    Wien Z Inn Med; 1962 May; 43():200-8. PubMed ID: 13893500
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of lymphoid hemoblastoses with a new colchicine derivative demelcolcine].
    STORTI E; GALLINELLI R
    Schweiz Med Wochenschr; 1954 May; 84(22):612-5. PubMed ID: 13168331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-Naphthyl-di-chlorethylamine therapy of malignant conditions, especially Hodgkin's disease].
    VIDEBAEK AA; KAAE S
    Ugeskr Laeger; 1954 Jun; 116(25):943-7. PubMed ID: 13187718
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological actions and therapeutic applications of nitrogen mustard.
    BEATTIE JW; HOWELLS LH
    Q J Med; 1954 Apr; 23(90):231-54. PubMed ID: 13155775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.